Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome.

about

Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome.

Item

http://www.wikidata.org/entity/Q55284980

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome.

@en

Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome.

@nl

type

Item

label

Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome.

@en

Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome.

@nl

prefLabel

Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome.

@en

Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome.

@nl

P1476

Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome

@en

P2093

Ahmed Chaudhary

http://www.w3.org/2001/XMLSchema#string

Ashraf Abugroun

http://www.w3.org/2001/XMLSchema#string

Gabriel Rodriguez

http://www.w3.org/2001/XMLSchema#string

P2860

Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

Efficacy of imatinib mesylate in a patient with idiopathic hypereosinophilic syndrome and severe heart involvement.

Imatinib-induced fatal acute liver failure

Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature.

The safety and side effects of monoclonal antibodies.

Novel therapies for hypereosinophilic syndromes.

Clinical management of the hypereosinophilic syndromes.

Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate.

Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate.

P304

6291614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2018/6291614

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Ashraf Abugroun

Ahmed Chaudhary

Gabriel Rodriguez

P577

2018-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29780651

http://www.w3.org/2001/XMLSchema#string

P932

5892290

http://www.w3.org/2001/XMLSchema#string